Tecsys (TSE:TCS) Posts Earnings Results

Tecsys (TSE:TCS) posted its quarterly earnings data on Thursday. The company reported C$0.21 EPS for the quarter, FiscalAI reports. The business had revenue of C$50.05 million for the quarter. Tecsys had a net margin of 2.09% and a return on equity of 5.99%.

Here are the key takeaways from Tecsys’ conference call:

• Record fiscal 2026 results: Tecsys reported record revenue and adjusted EBITDA, with adjusted EBITDA rising 50% to CAD 20 million from CAD 13 million. Management said expanding SaaS revenue and margins are driving an inflection point in profitability.
• SaaS remains the primary growth engine: SaaS revenue grew 20% in fiscal 2026 and now represents more than 40% of total revenue, while SaaS margins approached 70% and are targeted to reach 80% over time.
• Healthcare opportunity and AI momentum: Management highlighted a CAD 1.6 billion estimated recurring-revenue opportunity across major U.S. health systems, CAD 153 million of expansion potential within existing accounts, and positive early uptake of the TecsysIQ AI platform.
• Strong liquidity and shareholder returns: Tecsys ended the year with CAD 31 million in cash, cash equivalents and short-term investments, while returning capital through CAD 13 million of share repurchases and CAD 5 million of dividends.
• Restructuring reflects legacy-product pressure: The company restructured during the fourth quarter to address declining customer spending on certain legacy products and redirect investment toward future opportunities, resulting in some workforce reductions.

Tecsys Price Performance

Shares of TCS opened at C$28.55 on Friday. The firm has a market capitalization of C$411.61 million, a PE ratio of 105.74 and a beta of 0.84. The company’s 50-day moving average is C$32.01 and its 200-day moving average is C$32.20. Tecsys has a fifty-two week low of C$22.51 and a fifty-two week high of C$38.00. The company has a debt-to-equity ratio of 8.49, a current ratio of 1.12 and a quick ratio of 1.40.

Insider Activity at Tecsys

In related news, Director David Brereton sold 1,700 shares of Tecsys stock in a transaction dated Friday, July 17th. The shares were sold at an average price of C$33.00, for a total transaction of C$56,100.00. Following the completion of the sale, the director owned 714,572 shares of the company’s stock, valued at approximately C$23,580,876. The trade was a 0.24% decrease in their position. Over the last ninety days, insiders have sold 4,200 shares of company stock worth $133,322. Insiders own 17.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on TCS shares. National Bank Financial upgraded shares of Tecsys from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from C$40.00 to C$46.00 in a report on Wednesday, May 27th. Canaccord Genuity Group upgraded shares of Tecsys to a “strong-buy” rating in a research note on Thursday, August 6th. TD Securities raised shares of Tecsys to a “strong-buy” rating in a research report on Thursday, July 9th. Finally, TD set a C$39.00 price target on shares of Tecsys and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of C$38.70.

About Tecsys

Tecsys is trusted by mission-critical organizations in healthcare and distribution to build resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven software with deep domain expertise, Tecsys delivers real-time operational visibility and execution across critical workflows when performance and reliability matter most. Tecsys is publicly traded on the Toronto Stock Exchange (TCS). For more information, visit www.tecsys.com.